A citation-based method for searching scientific literature

Andrew Blauvelt, Russel Burge, William Malatestinic, Alan Brnabic, Jiaying Guo, Manju Janardhanan, Baojin Zhu. J Manag Care Spec Pharm 2021
Times Cited: 2







List of co-cited articles
26 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Indirect comparison of anti-interleukin 17 targeted biological treatments for moderate-to-severe psoriasis.
Rocío Díaz Acedo, Mercedes Galvan Banqueri, Esther Márquez Saavedra. J Clin Pharm Ther 2020
2
100

A Systematic Review With Network Meta-Analysis of the Available Biologic Therapies for Psoriatic Disease Domains.
Tiago Torres, Anabela Barcelos, Paulo Filipe, João Eurico Fonseca. Front Med (Lausanne) 2021
5
100

Network meta-analysis of biologic treatments for psoriasis using absolute Psoriasis Area and Severity Index values ≤1, 2, 3 or 5 derived from a statistical conversion method.
U Mrowietz, R B Warren, C L Leonardi, D Saure, H Petto, S Hartz, M Dossenbach, K Reich. J Eur Acad Dermatol Venereol 2021
4
100

Comparison of cumulative clinical benefits of biologics for the treatment of psoriasis over 16 weeks: Results from a network meta-analysis.
Richard B Warren, Melinda Gooderham, Russel Burge, Baojin Zhu, David Amato, Karen Huayu Liu, David Shrom, Jiaying Guo, Alan Brnabic, Andrew Blauvelt. J Am Acad Dermatol 2020
23
100

Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Emilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, Giao Do, Camille Hua, Canelle Mazaud, Catherine Droitcourt, Carolyn Hughes, John R Ingram, Luigi Naldi,[...]. Cochrane Database Syst Rev 2017
147
100


Comparative safety and benefit-risk profile of biologics and oral treatment for moderate-to-severe plaque psoriasis: A network meta-analysis of clinical trial data.
Neil H Shear, Keith A Betts, Ahmed M Soliman, Avani Joshi, Yan Wang, Jing Zhao, Paolo Gisondi, Ranjeeta Sinvhal, April W Armstrong. J Am Acad Dermatol 2021
5
100



Targeted therapies for patients with moderate-to-severe psoriasis: a systematic review and network meta-analysis of PASI response at 1 year.
Najeeda Yasmeen, Laura M Sawyer, Kinga Malottki, Lars-Åke Levin, Eydna Didriksen Apol, Gregor B Jemec. J Dermatolog Treat 2022
17
100


Comparative efficacy and safety of biologics in moderate to severe plaque psoriasis: a multiple-treatments meta-analysis.
Shanshan Xu, Xing Gao, Jixiang Deng, Jiajia Yang, Faming Pan. J Dtsch Dermatol Ges 2021
3
100

National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study.
Rosa Parisi, Ireny Y K Iskandar, Evangelos Kontopantelis, Matthias Augustin, Christopher E M Griffiths, Darren M Ashcroft. BMJ 2020
133
100

Rapid Response of Biologic Treatments of Moderate-to-Severe Plaque Psoriasis: A Comprehensive Investigation Using Bayesian and Frequentist Network Meta-analyses.
Richard B Warren, Kyoungah See, Russel Burge, Ying Zhang, Alan Brnabic, Gaia Gallo, Alyssa Garrelts, Alexander Egeberg. Dermatol Ther (Heidelb) 2020
18
100

A Systematic Literature Review and Bucher Indirect Comparison: Tildrakizumab versus Guselkumab.
Kristian Garn Du Jardin, Pepi Hurtado Lopez, Mette Lange, Rachael McCool, Silvia Maeso Naval, Sandra Quickert. J Health Econ Outcomes Res 2020
4
100

Comparison of Biologics and Oral Treatments for Plaque Psoriasis: A Meta-analysis.
April W Armstrong, Luis Puig, Avani Joshi, Martha Skup, David Williams, Junlong Li, Keith A Betts, Matthias Augustin. JAMA Dermatol 2020
68
100

Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta-analysis.
S K Mahil, M C Ezejimofor, L S Exton, L Manounah, A D Burden, L C Coates, M de Brito, A McGuire, R Murphy, C M Owen,[...]. Br J Dermatol 2020
22
100



Short-term effectiveness of biologics in patients with moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis.
Yayoi Tada, Rei Watanabe, Hisashi Noma, Yasumasa Kanai, Takanobu Nomura, Kenji Kaneko. J Dermatol Sci 2020
12
100

Etanercept and efalizumab for the treatment of psoriasis: a systematic review.
N Woolacott, N Hawkins, A Mason, A Kainth, Z Khadjesari, Y Bravo Vergel, K Misso, K Light, R Chalmers, M Sculpher,[...]. Health Technol Assess 2006
119
100

Efficacy of Brodalumab for Moderate to Severe Plaque Psoriasis: A Canadian Network Meta-Analysis.
Weiguang Xue, Paranjoy Saharia, Emma Gray, Shoghag Khoudigian-Sinani, Véronique Gaudet, Martin Barbeau, Kim Papp. J Cutan Med Surg 2020
5
100

Comparative effects of biological therapies on the severity of skin symptoms and health-related quality of life in patients with plaque-type psoriasis: a meta-analysis.
Kristian Reich, Rodney Sinclair, Graeme Roberts, Christopher E M Griffiths, Maggie Tabberer, Jonathan Barker. Curr Med Res Opin 2008
37
100

Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Emilie Sbidian, Anna Chaimani, Sivem Afach, Liz Doney, Corinna Dressler, Camille Hua, Canelle Mazaud, Céline Phan, Carolyn Hughes, Dru Riddle,[...]. Cochrane Database Syst Rev 2020
73
100

Long-term efficacy of novel therapies in moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis of PASI response.
L M Sawyer, L Cornic, L Å Levin, C Gibbons, A H Møller, G B Jemec. J Eur Acad Dermatol Venereol 2019
53
100

Comparison of two independent systematic reviews of trials of recombinant human bone morphogenetic protein-2 (rhBMP-2): the Yale Open Data Access Medtronic Project.
Jeffrey Low, Joseph S Ross, Jessica D Ritchie, Cary P Gross, Richard Lehman, Haiqun Lin, Rongwei Fu, Lesley A Stewart, Harlan M Krumholz. Syst Rev 2017
9
50


Evidence synthesis for decision making 1: introduction.
Sofia Dias, Nicky J Welton, Alex J Sutton, A E Ades. Med Decis Making 2013
106
50

Network Meta-analysis of Treatments for Chronic Plaque Psoriasis in Canada.
Aditya K Gupta, Deanne Daigle, Danika C A Lyons. J Cutan Med Surg 2014
10
50

Most randomized controlled trials for psoriasis used placebo comparators despite the availability of effective treatments.
Sivem Afach, Theodoros Evrenoglou, Nadia Oubaya, Laurence Le Cleach, Emilie Sbidian. J Clin Epidemiol 2021
1
100

Comparative efficacy and safety of thirteen biologic therapies for patients with moderate or severe psoriasis: A network meta-analysis.
Guomei Xu, Meng Xia, Chenjie Jiang, Ying Yu, Guomi Wang, Jiaojiao Yuan, Xingwu Duan. J Pharmacol Sci 2019
19
50


Cost-efficacy comparison of biological therapies for patients with moderate to severe psoriasis in Japan.
Atsuyuki Igarashi, Hiroyo Kuwabara, Kyle Fahrbach, Brad Schenkel. J Dermatolog Treat 2013
17
50

Number needed to treat and costs per responder among biologic treatments for moderate-to-severe plaque psoriasis in Japan.
Shinichi Imafuku, Ataru Nakano, Hidetoshi Dakeshita, Junlong Li, Keith A Betts, Annie Guerin. J Dermatolog Treat 2018
9
50

The comparative efficacy of brodalumab in patients with moderate-to-severe psoriasis: a systematic literature review and network meta-analysis.
Laura Sawyer, Iain Fotheringham, Emily Wright, Najeeda Yasmeen, Carl Gibbons, Anders Holmen Møller. J Dermatolog Treat 2018
21
50

Assessing the relative efficacy of interleukin-17 and interleukin-23 targeted treatments for moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis of PASI response.
Laura M Sawyer, Kinga Malottki, Celia Sabry-Grant, Najeeda Yasmeen, Emily Wright, Anne Sohrt, Emma Borg, Richard B Warren. PLoS One 2019
69
50

AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.
Beverley J Shea, Barnaby C Reeves, George Wells, Micere Thuku, Candyce Hamel, Julian Moran, David Moher, Peter Tugwell, Vivian Welch, Elizabeth Kristjansson,[...]. BMJ 2017
50

Biological treatments for moderate-to-severe psoriasis: indirect comparison.
M Galván-Banqueri, R Marín Gil, B Santos Ramos, F J Bautista Paloma. J Clin Pharm Ther 2013
31
50

Overlapping network meta-analyses on the same topic: survey of published studies.
F Naudet, E Schuit, J P A Ioannidis. Int J Epidemiol 2017
19
50

Evidence synthesis for decision making 7: a reviewer's checklist.
A E Ades, Deborah M Caldwell, Stefanie Reken, Nicky J Welton, Alex J Sutton, Sofia Dias. Med Decis Making 2013
48
50


A new classification of spin in systematic reviews and meta-analyses was developed and ranked according to the severity.
Amélie Yavchitz, Philippe Ravaud, Douglas G Altman, David Moher, Asbjørn Hrobjartsson, Toby Lasserson, Isabelle Boutron. J Clin Epidemiol 2016
68
50

Treatment modifying factors of biologics for psoriatic arthritis: a systematic review and Bayesian meta-regression.
Eric Druyts, Jacqueline B Palmer, Chakrapani Balijepalli, Keith Chan, Mir Sohail Fazeli, Vivian Herrera, Jeroen P Jansen, Jay J H Park, Steve Kanters, Andreas Reimold. Clin Exp Rheumatol 2017
6
50

Cost per additional responder for ixekizumab and other FDA-approved biologics in moderate-to-severe plaque psoriasis.
Sarah Al Sawah, Shonda A Foster, Russel Burge, David Amato, Alexander Schacht, Baojin Zhu, Susanne Hartz, Craig Leonardi. J Med Econ 2017
11
50

Efficacy of several biological therapies for treating moderate to severe psoriasis: A network meta-analysis.
Wenjun Geng, Jianhua Zhao, Jixing Fu, Huamin Zhang, Shaohua Qiao. Exp Ther Med 2018
13
50

Matching-adjusted indirect comparison of efficacy in patients with moderate-to-severe plaque psoriasis treated with ixekizumab vs. secukinumab.
R B Warren, A Brnabic, D Saure, R G Langley, K See, J J Wu, A Schacht, L Mallbris, A Nast. Br J Dermatol 2018
27
50

PRISMA for Abstracts: reporting systematic reviews in journal and conference abstracts.
Elaine M Beller, Paul P Glasziou, Douglas G Altman, Sally Hopewell, Hilda Bastian, Iain Chalmers, Peter C Gøtzsche, Toby Lasserson, David Tovey. PLoS Med 2013
325
50


Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis.
Zarif K Jabbar-Lopez, Zenas Z N Yiu, Victoria Ward, Lesley S Exton, M Firouz Mohd Mustapa, Eleanor Samarasekera, A David Burden, Ruth Murphy, Caroline M Owen, Richard Parslew,[...]. J Invest Dermatol 2017
85
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.